- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Csép K, Szigeti E, Vitai M, Korányi L
The Ppargc1A - Gly482Ser Polymorphism (RS8192678) and the Metabolic Syndrome in a Central Romanian Population
Acta Endo (Buc) 2017, 13 (2): 161-167doi: 10.4183/aeb.2017.161
Background. The peroxisome proliferatoractivated
receptor-γ co-activator 1-α (PPARGC1A), a key
transcription factor involved in the control of metabolism
and energy homeostasis, is an important biological and
positional candidate of the metabolic syndrome. Association
studies of its polymorphisms, however, yielded inconsistent
sometimes conflicting results, pointing to important ethnic
differences, which call for replication in various populations.
Objective. In order to study its most common
- potentially functional - polymorphism Gly482Ser
(rs8192678), we carried out a case-control study in a central
Romanian population.
Material and methods. Two hundred and ninety
six patients affected by the metabolic syndrome diagnosed
according to the International Diabetes Federation proposed
criteria and 166 middle-aged control subjects have been
investigated. Genotyping was done by PCR-RFLP, using the
restriction enzyme MspI.
Results. While the G(Gly)/A(Ser) allele frequencies
(66.89/33.11 vs. 71.68/28.31 %) and GG/GA/AA genotype
distribution (45.27-43.24-11.48 vs. 54.21-34.93-10.84 %)
differed in the metabolic syndrome and control group, the
risk of developing the metabolic syndrome did not reach the
limit of statistical significance (OR=1.43; p=0.06, CI 95%:
0.97-2.09). Metabolic parameters in the two study groups did
not show significant differences according to the genotype
(p>0.05).
Conclusion. rs8192678 could be a functional
polymorphism contributing to the development of the
metabolic syndrome, but probably its effect is minor,
and might depend on gene–gene and gene-environment
interactions. Clarification of very small effects would require
larger sample sizes.
Keywords: metabolic syndrome, PPARGC1A polymorphism
Correspondence: Katalin Csép, University of Medicine and Pharmacy, Tg. Mures – Genetics, 38 Gh. Marinescu street, Tg. Mures, E-mail: genetica.umftgmro@gmail.com